Pfizer withdraws Macugen for DMO in Europe
19 July 2011
Sukaina Virji
Please Login to read the full article.
19 July 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Gilenya and Tasigna drive new product growth at Novartis
- EMA confirms Champix' positive benefit-risk balance, but will review data in September
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- Bayer/J&J report positive Xarelto results in Japanese AF patients
